Clinical Trial: The efficacy and safety of Upadacitinib in the treatment of SAPHO syndrome (China)

China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The efficacy and safety of Upadacitinib in the treatment of SAPHO syndrome'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132526

Registration Time: 2026/09/15

Type: Observational study

Primary Sponsor: Shanghai Sixth People’s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336048

Published by HT Digital Content Services with permission from Health Daily Digest....